tci Medicare Compliance & Reimbursement - 2004 Issue 13
People: McClellan Confirmed At CMS
Subscribe or sign in to view the full article.
Article Overview
This article covers the Senate confirmation of Mark McClellan as administrator of the Centers for Medicare & Medicaid Services and the surrounding controversy over drug importation policy. It is relevant to readers tracking CMS leadership, federal health policy, and legislative activity affecting drug pricing and importation oversight. The piece summarizes the political context, stakeholder positions, and congressional responses discussed around the confirmation and hearing events.
Why This Topic Matters
It provides context on a CMS leadership change and the federal policy debate surrounding drug importation, both of which can affect Medicare and broader health policy developments.
What You Will Learn
- The context surrounding a CMS administrator confirmation
- How drug importation policy became part of the confirmation debate
- Which congressional and executive branch stakeholders were involved
- How the article frames broader efforts to address drug prices
Who Should Read This
- Medical coders tracking policy updates
- Health policy professionals
- Compliance and reimbursement teams
- Healthcare administrators
- Researchers monitoring CMS and federal legislation
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com